Develop a differential diagnosis for patients presenting with symptoms consistent with Fabry disease

This activity will provide learners with an opportunity to hear expert physicians discuss recently updated guidelines for HAE. The experts will cover important considerations in prophylactic treatment for HAE-C1INH, diagnosis and treatment for HAE-normal-C1INH, and how to create individualized HAE patient management plans.

Describe the pathogenesis of cold agglutinin disease (CAD), the mechanism of disease, its symptoms, and its possible consequences

Examine the patient, tumor, and/or treatment characteristics that may help guide clinical decision-making for patients with recurrent melanoma.

Upon completion of this activity, participants should be better able to integrate new information on IPF treatment into practice as it becomes available and discuss timing and rationale for starting antifibrotic therapy.

Don’t delay the diagnosis of PAH or overlook high-risk patients who should be screened. Find out how to optimize your use of echocardiography in this activity.  

Expert clinicians discuss optimal ways to diagnose and manage influenza during the end stages of the COVID-19 pandemic.